This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?
Diabetes, obesity & metabolism, 27 Suppl 7(Suppl 7), 3-13
Citation
Cowart, Kevin; Carris, Nicholas W. (2025). Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?. Diabetes, obesity & metabolism, 27 Suppl 7(Suppl 7), 3-13. https://doi.org/10.1111/dom.16502